Erectile dysfunction (ED) is associated with an increased risk of cardiovascular disease in healthy men. However, the association between treatment for ED and death or cardiovascular outcomes after a first myocardial infarction (MI) is unknown.
In a Swedish nationwide cohort study all men 5 dispensed prescriptions of phosphodiesterase-5 inhibitors was reduced by 34% (HR 0.66 (95% CI 0.38 to 1.15), 53% (HR 0.47 (95% CI 0.26 to 0.87) and 81% (HR 0.19 (95% CI 0.08 to 0.45), respectively, when compared with alprostadil treatment.
Treatment for ED after a first MI was associated with a reduced mortality and heart failure hospitalisation. Only men treated with phosphodiesterase-5 inhibitors had a reduced risk, which appeared to be dose-dependent.
Notes
Cites: Med J Aust. 2006 Oct 16;185(8):418-2217137429
Cites: J Sex Med. 2012 Aug;9(8):2104-1022759697
Cites: Circulation. 2013 Mar 19;127(11):1200-823406672
Cites: BMC Public Health. 2011 Jun 09;11:45021658213
Cites: Am J Physiol Heart Circ Physiol. 2002 Sep;283(3):H1263-912181158
Cites: Int J Impot Res. 2007 Jan-Feb;19(1):55-6116858368
Cites: JAMA. 2005 Dec 21;294(23):2996-300216414947
Cites: Int J Clin Pract. 2013 Nov;67(11):1163-7223714173
Cites: Int J Clin Pract. 2010 Jun;64(7):848-5720584218
Cites: Eur Heart J. 2013 Jul;34(27):2034-4623616415
Cites: Circulation. 2012 Mar 20;125(11):1341-322319107
Cites: Circulation. 2012 Mar 20;125(11):1390-40122319106
Cites: J Sex Med. 2009 Sep;6(9):2445-5419538544
Cites: Eur Heart J. 2006 Nov;27(22):2632-916854949
Cites: PLoS Med. 2013;10(1):e100137223382654
Cites: Ann Epidemiol. 2006 Feb;16(2):85-9016226038
Cites: J Sex Med. 2010 Jan;7(1 Pt 1):192-20219912508
Cites: Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):726-3516897791
Cites: J Sex Med. 2011 May;8(5):1445-5321366879
Cites: Circulation. 2010 Mar 30;121(12):1439-4620231536
Cites: J Am Coll Cardiol. 2008 May 27;51(21):2040-418498958